Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock. In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard. Wikipedia